» Go to news main
Zebrafish lead Dalhousie researchers to important discoveries in prostate cancer and leukemia
The zebrafish, a four- to six-centimetre minnow, has led researchers to remarkable revelations about the development and treatment of human disease.
These include a surprising discovery about prostate cancer, and a hopeful one for childhood leukemia, in studies led by Dr. Graham Dellaire and Dr. Jason Berman at Dalhousie.
Dr. Dellaire’s main interest is the treatment of solid tumours found in breast, lung and prostate cancer. He sees zebrafish as an important vehicle for developing personalized cancer therapies.
“If we can inject the embryo with cells from a human tumour and then introduce a range of chemotherapy treatments, we can figure out which one works best for a particular patient,” he says.
Read more on Dal News.
- CADTH Recognizes Rising Star Dr Michelle Mujoomdar
- Dal internist co‑authors paper for The Lancet on Canada’s health leadership obligations
- Molly Appeal to support advanced brain research with new tissue processing machine
- Entering the Den for a research prize
- Dal Med Innovator | Dr. Lea Steeves
- U.S. National Institutes of Health (NIH) awards Dal‑led project $3.2 million to develop new immunotherapy drugs for advanced melanoma
- New Canada 150 Research Chair in Vaccinology and Global Health to Call Dalhousie Home
- Dalhousie Original | Dr. Ford Doolittle